Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2003
02/18/2003US6521650 Amines as pharmaceutical agents
02/18/2003US6521643 Pyridine compounds and their pharmaceutical use
02/18/2003US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
02/18/2003US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity
02/18/2003US6521606 Matrix metalloproteinase inhibitors
02/18/2003US6521599 Carrier comprises glycine and aqueous hydrochloric acid; compatability; neutralization
02/18/2003US6521270 Compositions comprising nitrofurantoin and uva ursi
02/18/2003US6521225 AAV vectors
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/13/2003WO2003012441A1 Method for detecting modulators of notch signalling
02/13/2003WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003011899A2 Antigenic polypeptides
02/13/2003WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
02/13/2003WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
02/13/2003WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
02/13/2003WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
02/13/2003WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
02/13/2003WO2003011814A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
02/13/2003WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME
02/13/2003WO2003011810A1 Method for the nitration of phenolic compounds
02/13/2003WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/13/2003WO2003011396A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines
02/13/2003WO2003011395A2 Method of utilizing neurotrophins to manipulate reproductive capacity
02/13/2003WO2003011341A1 Solid composition containing bacillus-type non-pathogenic bacterial spores
02/13/2003WO2003011338A1 Regulation of gastric acid secretion by inwardly rectifying k+ channels
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011303A1 Dermal therapy using phosphate derivatives of electron transfer agents
02/13/2003WO2003011302A1 Androgen receptor modulators and methods of use thereof
02/13/2003WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
02/13/2003WO2003011276A1 Nf?b inhibitor
02/13/2003WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
02/13/2003WO2003011265A2 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds
02/13/2003WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes
02/13/2003WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
02/13/2003WO2003011227A2 Taste masking composition
02/13/2003WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
02/13/2003WO2003011210A2 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
02/13/2003WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes
02/13/2003WO2003011055A1 Nutritional composition preventing bacterial overgrowth
02/13/2003WO2003011042A1 Soluble roasted chicory with high inulin content
02/13/2003WO2002096855A3 Anticholinergic compounds and methods of use
02/13/2003WO2002078644A3 Use of ozone for the treatment of dental and oral conditions
02/13/2003WO2002076995A3 2-amino-propanol derivatives
02/13/2003WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
02/13/2003WO2002055492A3 An improved process for preparing pure ondansetron hydrochloride dihydrate
02/13/2003WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
02/13/2003WO2002046192A3 Thioether substituted imidazoquinolines
02/13/2003WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation
02/13/2003WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/13/2003WO2001072754A8 Alkylated imidazopyridine derivatives
02/13/2003US20030032834 Aminoalcohol derivatives
02/13/2003US20030032804 Methods of treating periodontal disease
02/13/2003US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase
02/13/2003US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders
02/13/2003US20030032670 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate
02/13/2003US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds
02/13/2003US20030032642 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD.
02/13/2003US20030032640 Novel composition
02/13/2003US20030032636 For the treatment of depression and other affective disorders.
02/13/2003US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat.
02/13/2003US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals
02/13/2003US20030032584 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal.
02/13/2003US20030032581 Pharmaceuticals for treating obesity
02/13/2003US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders
02/13/2003US20030032183 Induction of preferential stem cell differentiation; obtain nutrient broths, inoculate with cells, mix with modulator, propagate and recover cells
02/13/2003US20030032097 DNA encoding human vanilloid receptor VR3
02/13/2003US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
02/13/2003US20030031737 Medicinal composition and method of using it
02/13/2003US20030031732 Anti-fatigue and tonic agent containing wild ginseng
02/13/2003US20030031711 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
02/13/2003US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof
02/13/2003US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure
02/13/2003US20030031647 IFN-alpha and amantadine for treating hepatitis C
02/13/2003US20030031644 For therapy of microbial infection in mammal
02/13/2003CA2808598A1 Antigenic polypeptides
02/13/2003CA2457100A1 Taste masking composition
02/13/2003CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same
02/13/2003CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
02/13/2003CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
02/13/2003CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity
02/13/2003CA2455179A1 Androgen receptor modulators and methods of use thereof
02/13/2003CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2454935A1 Method for the nitration of phenolic compounds
02/13/2003CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones
02/13/2003CA2454136A1 5-aminolevulinic acid and esters, in combination with another photosensitizer, as photosensitizing agents in photochemotherapy, and their uses in_treating wounds
02/13/2003CA2453937A1 Antigenic polypeptides
1 ... 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 ... 1258